Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Keep patient, maybe we are at last step to the final victory

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on May 18, 2024 9:45pm

309 Views

Post# 36047657

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Keep patient, maybe we are at last step to the final victory

For goodness sake people, why waste your time creating these complicated and quite frankly incorrect theories about why it has taken so long to reply to the FDA's Pre-BTD questions? Why not just call Roger and ask?
If you did, the need to fabricate convoluted reasons for the delay may evaporate! Or is that to simple a solution, and its more fun to make stuff up?

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023